Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Danaher Corporation (DHR)

Healthcare Diagnostics & Research
195.00 $
-0.6% vs. previous close
Closing price · As of: 31. Jul 2026

Danaher Corporation (DHR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 83,464 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet DHR
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
36,992 48,222 45,295 46,649 47,833 62,082 76,161 83,184 84,350 84,488 77,542 83,464
9,431 7,837 6,665 6,850 7,094 25,597 13,802 11,648 15,883 13,937 9,497 12,756
3,006 791 964 630 788 19,912 6,035 2,586 5,995 5,864 2,078 4,615
3,006 791 964 630 788 19,912 6,035 2,586 5,995 5,864 2,078 4,615
3,634 2,985 3,186 3,522 3,112 3,268 4,810 5,443 5,064 4,637 4,390 3,913
1,832 1,573 1,709 1,841 1,631 1,628 2,292 2,767 2,765 2,594 2,330 2,489
2,203 2,826 2,354 2,455 2,511 2,302 3,262 3,790 3,956 5,605 6,074 5,531
16,964 21,015 23,827 25,139 22,581 22,713 35,420 41,184 37,276 41,608 40,497 43,151
7,369 10,545 11,818 11,667 10,283 9,750 21,282 22,843 19,821 20,746 18,568 17,817
13,542 24,458 22,219 20,281 19,606 31,800 36,384 38,007 34,260 30,998 27,992 30,930
5,396 6,170 6,874 4,792 4,842 4,932 7,402 8,140 8,389 8,274 6,798 6,807
72 845 2,595 195 52 370 200 215 758 1,875 678 2.0
1,875 1,392 1,485 1,510 1,495 1,514 2,049 2,569 1,856 1,766 1,753 1,844
3,402 12,025 9,674 10,327 9,689 21,517 21,193 22,168 19,086 16,707 15,500 18,416
23,378 23,690 23,003 26,358 28,214 30,271 39,766 45,167 50,082 53,486 49,543 52,534
20,323 21,012 20,704 22,806 25,163 24,166 27,159 32,827 39,205 41,074 44,188 46,891
716 709 700 706 710 726 719 737 737 743 737 711

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?